Test Catalog

Test

Code
W160
Name
CYP2C19
Notes
Description

Also known as: PLAVIX, W160
Orderable Code: W160
Test Contains (LOINC): CYP2C19 Genotype (57132-3); CYP2C19 Phenotype (79714-2) and CYP2C19 Specimen (31208-2)
SPECIMEN REQUIREMENTS
Sample Type: Whole Blood
Preferred Container: EDTA (Lavender Top) Tube
Alternate Container: See Additional Information
Sample Volume: 3.0 mL
Minimal Sample Volume: 0.6 mL, does not allow for repeat testing
Handling Instructions
Refrigerate specimen after collection.
Client Transport Temperature: Refrigerated
Specimen Stability: Ambient: 7 Days; Refrigerated: 1 Month; Frozen: 1 Month
Unsuitable Specimen: Heparinized whole blood. Plasma or serum specimens.
TESTING
Frequency: Tuesday
Expected Turn Around: 5 – 10 Days
Responsible Dept: Reference Lab
Referral Lab: SRL
Referral Lab Code: W160
CPT: 81225
Methodology: Multiplex polymerase chain reaction (PCR) with allele-specific primer extension (ASPE) and fluorescence tag sorting using a Luminex platform.
ADDITIONAL INFORMATION
Compliance Statement: This test was developed and its performance characteristics determined by Sonic Reference Laboratory (SRL). It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research. SRL is qualified to perform high complexity testing under the Clinical Laboratory Improvement Amendments (CLIA).
Notes: Prior Authorization Required